HomeMedical SpecialtiesCardiologySunnybrook first in Canada to implant Biotronik heart monitoring device with artificial...

Sunnybrook first in Canada to implant Biotronik heart monitoring device with artificial intelligence capabilities

Published on

Sunnybrook has introduced a new device that uses artificial intelligence (AI) and advanced detection algorithms to enhance the identification and management of irregular heart rhythms.

The BIOTRONIK Biomonitor IV Loop Recorder, recently approved by Health Canada, has already been implanted in five patients at Sunnybrook. The small cardiac monitoring device is used to monitor and record heart rhythms. By enabling timely detection and interpretation of heart rhythm abnormalities, or arrhythmias, implantable cardiac monitors can allow for earlier intervention for arrhythmias and may even prevent severe outcomes including stroke.

“What sets this device apart is its ability to detect “noise”. When a patient moves, has a muscle tremor or there’s a very loud noise, that can fool a traditional device into thinking there’s an abnormal heart rhythm,” explains Dr. Christopher Cheung, cardiologist and cardiac electrophysiologist in Sunnybrook’s Schulich Heart Program. “These ‘smart’ algorithms help our team to filter through the “noise” and exclude it, so we can focus on the really important heart rhythm findings. This is an important step in improving care for patients living with arrhythmias.”

Sunnybrook sees more than 6000 patients a year in its Arrhythmia Device Clinic. Suzette Turner, a nurse practitioner in the clinic, says the intelligent technology is an added boost to the existing benefits of this device.

“Not only do loop monitors provide long term monitoring for up to four years – but they are very small and discreet so patients don’t notice them,” says Suzette, adding the device weighs five grams, and involves a minimally invasive procedure. “Patients benefit as we can quickly pick up on significant arrhythmias enhancing the already substantial capabilities.” This guides decisions about a patient’s medication, other heart devices such as pacemakers or defibrillators, or in deciding if a procedure like a cardiac ablation is necessary.

The Canadian Cardiovascular Society estimates more than 1.5 million Canadians live with heart arrhythmias. With this new technology, Sunnybrook is setting a new standard for detecting and treating heart rhythm disorders across Canada.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK)...

More like this

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK)...

An individualized and equitable approach: Pregnancy care for people with disabilities

HN Summary • Sunnybrook’s Accessible Care Pregnancy Clinic provides individualized, fully accessible care for people...

First-in-Canada case of sustained HIV remission

HN Summary • A first-in-Canada case shows a patient achieving sustained HIV remission following a...